Disorders of the Wnt/β signalling pathway, tyrosine kinase receptor signalling pathway, vascular endothelial growth factor (VEGF) pathway, JAK/STAT pathway, and transforming growth factor-beta pathway (TGF-β) are commonly reported in relation to HCC pathophysiology [2]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.